Related Experiment Videos
T-cell prolymphocytic leukemia. Clinical and immunologic characterization.
Cancer
|December 1, 1983
Summary
T-cell prolymphocytic leukemia (T-PLL) can present with extensive skin involvement. This aggressive leukemia, regardless of T-cell phenotype, has a poor prognosis and is a distinct entity from chronic lymphocytic leukemia.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive lymphoid malignancy.
- Understanding the cell surface markers and clinical presentation of T-PLL is crucial for diagnosis and treatment.
Observation:
- A case of T-PLL with extensive skin involvement is presented.
- Malignant cells were analyzed using cytochemistry and monoclonal antibodies.
- Leukemic cells showed a phenotype similar to normal post-thymic suppressor T-cells.
Findings:
- T-PLL appears to originate from lymphocytes with either suppressor or helper T-cell phenotypes.
- Extensive skin infiltration in T-PLL may not be directly related to the cell's phenotype.
- T-PLL shares some features with chronic lymphocytic leukemia but is a distinct, aggressive disease.
Implications:
- T-PLL requires recognition as a separate pathological entity due to its aggressive nature.
- The average survival for T-PLL is approximately 6 months.
- Further research into T-PLL pathogenesis and treatment is warranted.